Article
Dynamic behavior and ligand binding properties of the wild type dCK and its characterized gemcitabine-resistant variant: a bioinformatics and computational study
2022-06-02
Abstract excerpt
In order to control the cell proliferation in various types of cancers, gemcitabine as the analogue of deoxycytidine is being used to perturb the DNA synthesis. The main challenge in using gemcitabine includes resistance of some patients to this compound due to the genetic mutations on deoxycytidine kinase (dCK) that are found in a fraction of human population. Here, we investigated the dynamics behavior and ligan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c2bbe451-8efe-5b2e-99b0-dcb13cf44a7f
- DOI
- 10.21203/rs.3.rs-1661054/v1
